These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 22210097

  • 1. Therapeutic drug monitoring of voriconazole in children.
    Chen J, Chan C, Colantonio D, Seto W.
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
    Seyedmousavi S, Mouton JW, Verweij PE, Brüggemann RJ.
    Expert Rev Anti Infect Ther; 2013 Sep; 11(9):931-41. PubMed ID: 24053274
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Gerin M, Mahlaoui N, Elie C, Lanternier F, Bougnoux ME, Blanche S, Lortholary O, Jullien V.
    Ther Drug Monit; 2011 Aug; 33(4):464-6. PubMed ID: 21743382
    [Abstract] [Full Text] [Related]

  • 5. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P, Frick MA, Martín-Nalda A, Lanaspa M, Pou L, Roselló E, de Heredia CD, Figueras C.
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [Abstract] [Full Text] [Related]

  • 6. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA, Kuhn DM.
    Eur J Med Res; 2002 May 31; 7(5):242-56. PubMed ID: 12069915
    [Abstract] [Full Text] [Related]

  • 7. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O.
    Clin Infect Dis; 2008 Jan 15; 46(2):201-11. PubMed ID: 18171251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A, Hoffman J, Sheth A.
    Ann Pharmacother; 2008 Dec 15; 42(12):1859-64. PubMed ID: 19017830
    [Abstract] [Full Text] [Related]

  • 10. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
    Pascual A, Nieth V, Calandra T, Bille J, Bolay S, Decosterd LA, Buclin T, Majcherczyk PA, Sanglard D, Marchetti O.
    Antimicrob Agents Chemother; 2007 Jan 15; 51(1):137-43. PubMed ID: 17088483
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology and clinical use of voriconazole.
    Thompson GR, Lewis JS.
    Expert Opin Drug Metab Toxicol; 2010 Jan 15; 6(1):83-94. PubMed ID: 19947892
    [Abstract] [Full Text] [Related]

  • 12. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA, Wenzel RP.
    Expert Rev Hematol; 2009 Jun 15; 2(3):237-54. PubMed ID: 21082966
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring of voriconazole.
    Brüggemann RJ, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NM, Mouton JW, Verweij PE, Burger DM.
    Ther Drug Monit; 2008 Aug 15; 30(4):403-11. PubMed ID: 18641555
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole plasma monitoring.
    Pasqualotto AC, Shah M, Wynn R, Denning DW.
    Arch Dis Child; 2008 Jul 15; 93(7):578-81. PubMed ID: 18252755
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    Clifton IJ, Whitaker P, Metcalfe R, Phillip M, Shaw N, Conway SP, Peckham DG.
    J Antimicrob Chemother; 2011 Oct 15; 66(10):2438-40. PubMed ID: 21791443
    [No Abstract] [Full Text] [Related]

  • 16. Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Rüping MJ, Müller C, Vehreschild JJ, Böhme A, Mousset S, Harnischmacher U, Frommolt P, Wassmer G, Drzisga I, Hallek M, Cornely OA.
    Mycoses; 2011 May 15; 54(3):230-3. PubMed ID: 19889174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Level of evidence for therapeutic drug monitoring of voriconazole].
    Hulin A, Dailly E, Le Guellec C, Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique.
    Therapie; 2011 May 15; 66(2):109-14. PubMed ID: 21635857
    [Abstract] [Full Text] [Related]

  • 19. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ, Simpson D.
    Drugs; 2007 May 15; 67(2):269-98. PubMed ID: 17284090
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
    Spriet I, Wauters J, Willems L.
    Ther Drug Monit; 2011 Jun 15; 33(3):372; author reply 372. PubMed ID: 21566509
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.